Figure 2
Mutation status of AML1-ETO, PML-RARα, CBFβ-MYH11, FLT3, C-KIT, N-RAS, NPM1, CEBPA, WT1, ASXL1, DNMT3A, MLL, IDH1, IDH2, and TET2. Black shadow indicates mutation cases.
Mutation status of AML1-ETO, PML-RARα, CBFβ-MYH11, FLT3, C-KIT, N-RAS, NPM1, CEBPA, WT1, ASXL1, DNMT3A, MLL, IDH1, IDH2, and TET2. Black shadow indicates mutation cases.
